M Baggott, J Mendelson, R Jones. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Hallucinogens/adverse effectsHumansN-Methyl-3,4-methylenedioxyamphetamine/adverse effectsParkinson Disease, Secondary/chemically inducedTime Factors
Substances: See more » HallucinogensN-Methyl-3,4-methylenedioxyamphetamine
Year: 1999 PMID: 10577097
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245